Published in Scand J Infect Dis on January 01, 1999
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet (1991) 4.31
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol (1992) 2.91
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med (1982) 1.40
Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience. Br Med J (1974) 1.35
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Wound infection after cesarean section. Infect Control (1986) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Mycoplasma pneumoniae infection associated with affection of the central nervous system. Acta Med Scand (1979) 1.30
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle. J Clin Microbiol (2003) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Bacteraemia in surgical patients with intravenous devices: a European multicentre incidence study. The European Working Party on Control of Hospital Infections. J Hosp Infect (1983) 1.22
Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect (1991) 1.20
HLA--A, B haplotype frequencies in 5,202 unrelated Danes by a maximum-likelihood method of gene counting. Tissue Antigens (1979) 1.17
Examination for tubercle bacili by fluorescence microscopy. Scand J Respir Dis (1966) 1.17
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet (1987) 1.15
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood (1990) 1.12
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level. Br J Obstet Gynaecol (1987) 1.03
Post-operative wound sepsis in general surgery. IV. Sources and routes of infection. Acta Chir Scand (1970) 1.03
Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. J Travel Med (2000) 1.02
A multicenter questionnaire investigation of attitudes toward hand hygiene, assessed by the staff in fifteen hospitals in Denmark and Norway. Am J Infect Control (1992) 1.00
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Maternal serum markers in screening for Down syndrome. Clin Genet (1990) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Factors influencing absorption of penicillin V. Acta Pathol Microbiol Scand (1967) 0.98
Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis (1993) 0.98
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with size of alpha-hemolysin production. APMIS (1988) 0.96
Immune response to diphtheria booster vaccine in the Baltic states. J Infect Dis (2000) 0.95
Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica (1998) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Isolation of human peripheral blood monocytes: a comparative methodological study. J Immunol Methods (1979) 0.92
Diagnostic assessment of haemorrhagic rash and fever. Arch Dis Child (2001) 0.92
Indirect haemagglutination test using gonococcal pilus antigen: how useful to diagnose gonorrhoea? Genitourin Med (1987) 0.92
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
A simplified plaque technique for titration of pox virus and its antibodies in chick embryo cells. Acta Pathol Microbiol Scand (1966) 0.91
Occurrence of sexual behaviour related to the risk of HIV-infection. A survey among Danish men, 16-55 years of age. Dan Med Bull (1989) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scand J Infect Dis (1995) 0.91
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
Epidemiology of pertussis in Denmark: the impact of herd immunity. Int J Epidemiol (1994) 0.90
In vitro studies on normal, stimulated and immunologically activated mouse macrophages. III. Intracellular multiplication of Listeria monocytogenes. Acta Pathol Microbiol Scand C (1977) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine (2000) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
Correlation between in vivo and in vitro functional tests for activated macrophages. Infect Immun (1979) 0.87
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
In vitro effect of mitogen-activated speen cells and their culture supernatants on mouse peritoneal macrophages as assayed by intracellular killing of Listeria monocytogenes and content of beta-galactosidase. J Reticuloendothel Soc (1979) 0.86
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg (1997) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome. Prenat Diagn (1999) 0.86